# Correction: Liu et al. Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. J. Clin. Med. 2023, 12, 1861

**Authors:** Yang Liu, Chang-Lin Wang, Zhong-Qi Pang, Ke Gao, Lin-Kun Shen, Wan-Hai Xu, Ming-Hua Ren

PMC · DOI: 10.3390/jcm13133943 · 2024-07-05

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, COL18A1 (collagen type XVIII alpha 1 chain) [NCBI Gene 80781] {aka GLCC, KNO, KNO1, KS}
- **Diseases:** Prostate Cancer (MESH:D011471)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11242116/full.md

---
Source: https://tomesphere.com/paper/PMC11242116